Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases

NCT05027711 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
90
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital Heidelberg